Surgical Management and Outcomes of Elderly Patients With Early Stage Non-small Cell Lung Cancer A Nested Case-Control Study

被引:55
作者
Rivera, Caroline [1 ]
Falcoz, Pierre-Emmanuel [2 ]
Bernard, Alain [3 ]
Thomas, Pascal A. [4 ]
Dahan, Marcel [5 ]
机构
[1] Univ Bordeaux, CHU Bordeaux, Haut Leveque Hosp, Dept Thorac Surg, Bordeaux, France
[2] Univ Strasbourg, Civil Hosp, Dept Thorac Surg, Strasbourg, France
[3] Univ Dijon, Bocage Hosp, Dept Thorac Surg, F-21004 Dijon, France
[4] Univ Marseille, North Hosp, Dept Thorac Surg, Marseille, France
[5] Univ Toulouse, Larrey Hosp, Dept Thorac Surg, Toulouse, France
关键词
PULMONARY RESECTION; WEDGE RESECTION; AGE; OCTOGENARIANS; MORTALITY; LOBECTOMY; RISK; SURVIVAL;
D O I
10.1378/chest.10-2841
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: The number of oncogeriatric patients with non-small cell lung cancer (NSCLC) is expected to increase in the next decades. Methods: We used the French Society of Thoracic and Cardiovascular Surgery database Epithor that includes information on >140,000 procedures from 98 institutions. We prospectively collected data from January 2004 to December 2008 on 1 969 patients aged >= 70 years with NSCLC stage I or II and matched them with 1,969 control subjects aged <70 years for sex, American Society of Anesthesia score, performance status, and FEV1. Surgical treatment and postoperative outcomes were compared between the two age groups. Results: The absence of radical lymphadenectomy was more frequent in the older patients (14%, n = 269) than in the younger patients (9%, n = 170) (P < .0001). There was no significant difference in type of resection between older and younger patients, respectively (pneumonectomy, 8% [n = 164] vs 11% [n = 216]; lobectomy, 79% [n = 1,559] vs 77% [n = 1,521]; bilobectomy, 4% [n = 88] vs 5% [n = 97]; sublobar resection, 7% [n = 143] vs 6% [n = 118]; P = .08). Differences in number (P = .07) and severity (P = .69) of complications were not significant. Postoperative mortality was higher in elderly patients at every end point (30-day mortality, 3.6% [n = 70] vs 2.2% [n = 43] [P = .01]; 60-day mortality, 4.1% [n = 80] vs 2.4% [n = 47] [P = .003]; 90-day mortality, 4.7% [n = 93] vs 2.5% [n = 50] [P = .0002]). Conclusions: Elderly patients with NSCLC should not he denied pulmonary resection on the basis of chronologic age alone. Among patients aged >= 70 years, 90-day mortality compared acceptably with mortality among younger matched patients. Additionally, the data show that for older patients, a 90-day mortality better represents their real mortality risk than 30- or 60-day figures. Our contemporary, multiinstitutional data importantly reveal that elderly patients, compared with their younger counterparts, do not have increased morbidity, incidence, or severity after pulmonary resection. CHEST 2011; 140(4):874-880
引用
收藏
页码:874 / 880
页数:7
相关论文
共 50 条
  • [1] Factors Determining the Choice of Surgical Procedure in Elderly Patients with Non-Small Cell Lung Cancer
    Okamoto, Junichi
    Kubokura, Hirotoshi
    Usuda, Jitsuo
    ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2016, 22 (03) : 131 - 138
  • [2] Survival in the Elderly after Pneumonectomy for Early-Stage Non-Small Cell Lung Cancer: A Comparison with Nonoperative Management
    Speicher, Paul J.
    Ganapathi, Asvin M.
    Englum, Brian R.
    Onaitis, Mark W.
    D'Amico, Thomas A.
    Berry, Mark F.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2014, 218 (03) : 439 - 449
  • [3] Outcomes in Thoracic Surgical Management of Non-Small Cell Lung Cancer
    von Ballmoos, Moritz C. Wyler
    Johnstone, David W.
    JOURNAL OF SURGICAL ONCOLOGY, 2014, 110 (05) : 539 - 542
  • [4] Perioperative outcomes of robotic lobectomy for early-stage non-small cell lung cancer in elderly patients
    Gallina, Filippo Tommaso
    Taje, Riccardo
    Forcella, Daniele
    Gennari, Valeria
    Visca, Paolo
    Pierconti, Federico
    Coccia, Cecilia
    Cappuzzo, Federico
    Sperduti, Isabella
    Facciolo, Francesco
    Melis, Enrico
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] Predictors and Outcomes of Limited Resection for Early-Stage Non-Small Cell Lung Cancer
    Billmeier, Sarah E.
    Ayanian, John Z.
    Zaslavsky, Alan M.
    Nerenz, David R.
    Jaklitsch, Michael T.
    Rogers, Selwyn O.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (21): : 1621 - 1629
  • [6] Progress in the Treatment and Outcomes for Early-Stage Non-Small Cell Lung Cancer
    Shin, Jacob Y.
    Yoon, Ja Kyoung
    Marwaha, Gaurav
    LUNG, 2018, 196 (03) : 351 - 358
  • [7] Adjuvant Chemotherapy in Elderly Patients with Early-stage Non-small Cell Lung Cancer
    Kefeli, Umut
    Kaymaz, Samet
    Aydin, Dincer
    Isik, Deniz
    Cabuk, Devrim
    Sonkaya, Alper
    Acikgoz, Ozgur
    Isik, Ulas
    Ozden, Ercan
    Uygun, Kazim
    BEZMIALEM SCIENCE, 2019, 7 (04): : 265 - 270
  • [8] Sublobar resection versus lobectomy in Surgical Treatment of Elderly Patients with early-stage non-small cell lung cancer (STEPS): study protocol for a randomized controlled trial
    Yang, Fan
    Sui, Xizhao
    Chen, Xiuyuan
    Zhang, Lixue
    Wang, Xun
    Wang, Shaodong
    Wang, Jun
    TRIALS, 2016, 17
  • [9] Stereotactic Ablative Radiation Therapy is Highly Safe and Effective for Elderly Patients With Early-stage Non-Small Cell Lung Cancer
    Brooks, Eric D.
    Sun, Bing
    Zhao, Lina
    Komaki, Ritsuko
    Liao, Zhonxing
    Jeter, Melenda
    Welsh, James W.
    O'Reilly, Michael S.
    Gomez, Daniel R.
    Hahn, Stephen M.
    Heymach, John V.
    Rice, David C.
    Chang, Joe Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (04): : 900 - 907
  • [10] Surgical treatment for early stage non-small cell lung cancer
    Raman, Vignesh
    Yang, Chi-Fu Jeffrey
    Deng, John Z.
    D'Amico, Thomas A.
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S898 - S904